Mr. Shah advises fintech companies on banking and finance regulations impacting all aspects of their development from startup to M&A exit. His broad experience working in government, private practice and in-house, has equipped him to understand the perplexing array of legal and competitive issues facing clients in the fintech industry.

Mr. Fackler has more than 20 years advising companies and financial sponsors across a range of industries on complex mergers, acquisitions and related transactions totaling more than $250 billion. Before moving to California, he was in private practice at Wachtell and worked in the financial sector.

Mr. Rieger focuses on all aspects of patent portfolio development primarily in the field of chemistry including pharmaceuticals, agrochemicals, and polymers. He advises pharmaceutical and biotechnology companies on pharmaceutical life cycle management, and also works with corporate and venture investors on IP due diligence associated with M&A transactions, private financings, and IPOs.

Elizabeth Evans represents a range of financial institutions, investors, and agencies in transactions and compliance matters across the aerospace industry. She focuses on aviation finance, and heads the air finance practice in the Americas for K&L Gates. She also advises clients on commercial space law, including joint ventures, capital raises, and space regulatory matters.

Jing Liu was recruited to expand Sheppard Mullin’s life science practice in California. With a Ph.D. in Biology from the University of Kansas Medical Center, Dr. Liu has extensive experience managing patents and related intellectual property assets, and negotiating transactions. Her expertise spans a range of biotechnology specialties including oncology, gene therapy, industrial biotechnology, diagnostics, genomics, bioinformatics, and microbiome-related technologies.

Kenneth E. Jenkins was the Managing Partner of Kilpatrick Townsend & Stockton’s San Diego office when he was recruited to expand the California life science IP practice at Mintz Levin. With a Ph.D. in Chemistry and Biochemisty from the University of Colorado, Dr. Jenkins has extensive experience with disruptive bioscience and chemical technologies, including pharmaceutical formulations, immuno- oncotherapies, small molecule therapeutics, stem cell therapies, antibody therapeutics, green industrial chemical production, enhanced oil recovery, interfering RNA technologies, proteomics, and nanotechnologies. He works closely with research institutions and innovative companies in the health care, life science, and energy technology industries to procure patents on cornerstone technologies and strategically manage patent portfolios to maximize investments. He has been recognized repeatedly as one of Southern California’s leading attorneys.

Terri Shieh-Newton was Co-Chair of Morrison & Foerster’s Stem Cell and Regenerative Medicine Group when she was recruited to launch the California life science patent practice for Mintz Levin. With a Ph.D. in Cellular and Molecular Medicine from Johns Hopkins School of Medicine, her expertise encompasses antibodies, biologics and biosimilars, immuno-oncology (including chimeric T-antigen receptors), immunotherapy, gene editing (e.g., CRISPR technology), gene therapy, synthetic biology, microbiomes, enzymes, protein engineering, protein production and therapeutics, vaccines and adjuvants, diagnostics and biomarkers. Dr. Shieh-Newton has worked with a variety of organizations in the life science field, including Genentech, DuPont/Danisco/Genencor, Regeneron, Roche, the University of California, and Stanford University.

Dan Herling is a trial lawyer who represents clients in the pharmaceutical and medical device industries. His practice emphasizes complex litigation, including product liability defense, class actions, and intellectual property disputes. He has defended more than 3,000 product liability cases in both state and federal courts throughout California and the United States.

Mr. Nibley is a highly-respected member of the government contracts bar, with innovative clients in such industries as aerospace, information technology, healthcare, and emerging technologies. He has three decades of experience in the counseling and resolution of defense and civilian contractor disputes, including 15 years as the chair of a national law firm's Government Contracts group.

Mr. Walters left Morrison & Foerster to launch the patent litigation group in Davis Wright Tremaine’s San Francisco office. He is a seasoned patent litigator with more than 20 years of experience handling a range of intellectual property and commercial disputes. Mr. Walters represents clients in the biotechnology, software, semiconductor, medical device and cleantech industries.

David Enzminger joined Winston & Strawn’s Los Angeles office and two years later launched the firm’s Silicon Valley office. Mr. Enzminger is a successful trial lawyer with a strong record as lead counsel in complex patent trials and over 20 years of experience in patent, trade secret, trademark, and antitrust disputes for clients in the telecommunications, electronics, computer hardware, and software industries.

Ms. Frankle was Chair of DLA's Public Company and Corporate Governance practice immediately prior to launching the Silicon Valley corporate practice of Kaye Scholer (now Arnold & Porter). A nationally-recognized expert in M&A transactions and corporate governance with an unparalleled reputation for advising boards of directors and special committees, Mrs. Frankle has deep roots in the Silicon Valley and its unique deal environment, having practiced at DLA and its predecessor firms for over 25 years.

Michael Malecek is an experienced trial attorney focusing on patent litigation for clients in the life sciences industry. A former assistant U.S. attorney with expertise in white collar litigation involving technology-related crimes, he was named one of the Daily Journal's "Top 75 Litigators" in California for 2010. Two years after joining Kaye Scholer (now Arnold & Porter), Mr. Malecek was made co-chair of the firm's Intellectual Property Department.

Peter Root focuses on complex business and commercial litigation for high technology and life science companies, with an emphasis on intellectual property and technology matters, securities and corporate governance litigation, and claims arising from mergers and acquisitions.

Mr. Holland is a patent partner with a focus on technologies critical to cleantech and renewable energy companies: solar energy, waste handling, water purification, alternate fuels, and solar cells. His clients run the gamut from startups and emerging growth companies to Fortune 500 companies.

Ms. Tan focuses on IP counseling, procurement, and enforcement. She is a former NASA research scientist, with a background that includes communication networks and devices, computer architecture, software and internet applications, semiconductor processing and devices.

Mr. Mercer represents clients in traditional and innovative industries from electronics to life sciences and information technology. He once served as general counsel and chief financial officer of a publicly traded telecommunications software company. He handles public and private securities offerings, domestic and cross-border mergers & acquisitions, and related matters. Since joining the firm, Mr Mercer has served in leadership roles including as co-chair of the Corporate Practice Group.

Mr. Greguras is a Silicon Valley corporate lawyer with decades of experience representing companies in the software, internet, clean technology, media and life science industries from formation to exit. He served as a general counsel and CFO, and has substantial experience representing companies with operations or a market interest in Asia.

Mr. Bach is a patent partner who has advised technology companies from the Silicon Valley to the Pacific Rim and Israel, including significant experience with Japanese, Korean, Taiwanese, and Chinese companies. He served as senior director of intellectual property with Applied Materials, where he was responsible for all aspects of IP internationally for the world's largest supplier of equipment to the global semiconductor industry.

Greg Bishop is a patent litigation partner who was recruited along with a group of his partners from IP boutique Townsend and Townsend and Crew to help launch the Silicon Valley office of Goodwin Procter. He focuses on patent litigation involving computers, electronics, and software.

April Abele is a patent litigation partner who was recruited along with a group of her partners from IP boutique Townsend and Townsend and Crew to help launch the Silicon Valley office of Goodwin Procter. She focuses on patent litigation for clients in the life science industry.

Cole, Raywid & Braverman, a 35-attorney communications and Internet law boutique based in Washington, DC, was aquired by Davis Wright Tremaine. The acquisition more than doubled Davis Wright's footprint in the nation's capital, and expanded the firm's communications, media and technology practice group to 120 lawyers.

Mr. Ellisen joined Greenberg Traurig from Foley & Lardner's Silicon Valley office. He had previously been firmwide chair of the intellectual property practice group at Oppenheimer, Wolff & Donnelly. His experience includes patent infringement lawsuits in federal district courts and before the International Trade Commission, as well as copyright, trademark, and trade secret cases.

Mr. Ubell joined Greenberg Traurig from Paul, Hastings, Janofsky & Walker, where he represented clients in high stakes patent litigation involving semiconductors, computer software, computer networking, and telecommunications technologies. He became the leader of Greenberg Traurig's intellectual property practice in Orange County, and recruited former colleagues to expand the office.

Ms. Stagg is a complex business litigator with extensive experience in consumer class-action defense for clients in the telecommunications industry. She was attracted to Fish & Richardson by the opportunity to expand the firm’s litigation bench beyond patent litigation, and serve the firm’s clients in high technology industries including semiconductor fabrication and software development.

Mr. Levy very early in his career developed a significant biotechnology patent practice. He joined Davis Wright when the firm's biotech practice consisted of just two attorneys in Seattle. Less than six years later, he had became co-chair of Davis Wright’s life science practice, which had expanded to include 18 attorneys across the Seattle, San Francisco, and Los Angeles offices, making it one of the largest biotech patent practices on the West Coast.

Mr. Radlo had spent 14 years as a patent partner at Fenwick & West and headed Fenwick's lateral recruiting committee for patent prosecutors for 10 years prior to joining Sonnenschein (now Dentons). He focused on computer security and encryption technologies critical to protecting against hackers. Mr. Radlo joined Sonnenschein to lead the firm's patent group in San Francisco.

Greg Lippetz joined Bingham soon after its merger with McCutchen Doyle to expand the firm’s patent litigation practice in California. At the time of his move, his practice emphasized complex high-stakes patent litigation for companies in the telecommunications equipment, computer hardware, and software industries. Mr. Lippetz attained success early in his career: The Daily Journal recognized him as a $5 million rainmaker in his 11th year of practicing law.

Joe Price and his partner, Al Gess, were recruited by Snell & Wilmer to launch the firm's intellectual property practice in Southern California. Prior to joining Snell & Wilmer, they had established a four-attorney IP boutique known as Price & Gess, which specialized in patent prosecution, licensing, and litigation, as well as trademark and copyright matters. Mr. Price had a particular focus on clients based in Japan who were engaged in business in the United States.

Al Gess and his partner, Joe Price, were recruited by Snell & Wilmer to launch the firm's intellectual property practice in Southern California. Prior to joining Snell & Wilmer, they had established a four-attorney IP boutique known as Price & Gess, which specialized in patent prosecution, licensing, and litigation, as well as trademark and copyright matters.

Charles Berman and his partner, Christopher Darrow, were recruited to lead the West Coast intellectual property practice for Greenberg Traurig. At the time of their move, the two partners had more than 45 years of combined experience in intellectual property law including patent prosecution, litigation, and transactions. They represented clients from a variety of industries, including biotechnology, electronics, clinical diagnostics, and entertainment.

Chris Darrow and his partner, Charles Berman, were recruited to lead the West Coast intellectual property practice for Greenberg Traurig. At the time of their move, the two partners had more than 45 years of combined experience in intellectual property law including patent prosecution, litigation, and transactions. They represented clients from a variety of industries, including biotechnology, electronics, clinical diagnostics, and entertainment.

Marc Brown was recruited along with four of his partners from Oppenheimer Wolff & Donnelly to launch McDermott Will & Emery’s patent litigation and prosecution practice in Los Angeles. Mr. Brown is highly regarded for his extensive expertise in procurement, evaluation, and enforcement of high technology patents, including his management of one of the largest patent infringement lawsuits ever filed. He had been the managing partner of Oppenheimer's Los Angeles office at the time of the group's move to McDermott Will.